Physician profile
Robert Grimshaw
NPI 1174562912
$479.22
in general payments reported to CMS, 2019-2025
12 companies · $61.16 in 2025
The $61.16 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.24 · 2022: $161 · 2023: $17.15 · 2024: $227 · 2025: $61.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255 · Long Term Medical Supply Or Device Loan: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.33 |
| Long Term Medical Supply Or Device Loan | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $226.10 | 2022-2025 | Freestyle Insulinx, Freestyle Libre 3 |
| Novo Nordisk INC | $62.16 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $33.88 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $30.10 | 2024 | Airsupra, Farxiga |
| Horizon Therapeutics Plc | $17.85 | 2022 | |
| Astellas Pharma US INC | $17.18 | 2024 | Veozah |
| Rgh Enterprises LLC | $17.15 | 2023 | |
| Insulet Corporation | $16.34 | 2024 | Omnipod |
| Cequr Corporation | $16.28 | 2024 | Cequr Simplicity |
| Dexcom, INC. | $14.48 | 2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $14.46 | 2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Grimshaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.